News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
251,154 Results
Type
Article (11908)
Company Profile (18)
Press Release (239228)
Section
Business (88970)
Career Advice (504)
Deals (13753)
Drug Delivery (20)
Drug Development (30623)
Employer Resources (54)
FDA (6217)
Job Trends (5300)
News (139964)
Policy (11154)
Tag
2024 BioMidwest Digital (3)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (2)
2024 Genetown Standard (2)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (1)
Academia (894)
Adcomms (14)
Allergies (24)
Alliances (16946)
ALS (20)
Alzheimer's disease (465)
Antibody-drug conjugate (ADC) (37)
Approvals (6279)
Artificial intelligence (74)
Autoimmune disease (3)
Automation (3)
Bankruptcy (84)
Best Places to Work (4442)
BIOSECURE Act (3)
Biosimilars (33)
Biotechnology (12)
Bladder cancer (17)
Brain cancer (9)
Breast cancer (132)
Cancer (802)
Cardiovascular disease (47)
Career advice (423)
Career pathing (10)
CAR-T (38)
Cell therapy (124)
Cervical cancer (10)
Clinical research (25796)
Collaboration (247)
Compensation (56)
Complete response letters (3)
COVID-19 (638)
CRISPR (14)
C-suite (91)
Cystic fibrosis (27)
Data (817)
Decentralized trials (1)
Denatured (3)
Depression (7)
Diabetes (121)
Diagnostics (2396)
Digital health (8)
Diversity (1)
Diversity, equity & inclusion (15)
Drug discovery (32)
Drug pricing (14)
Drug shortages (3)
Duchenne muscular dystrophy (17)
Earnings (46528)
Editorial (4)
Employer branding (9)
Employer resources (48)
Events (34994)
Executive appointments (228)
FDA (6644)
Featured Employer (6)
Frontotemporal dementia (4)
Funding (175)
Gene editing (30)
Generative AI (7)
Gene therapy (81)
GLP-1 (206)
Government (1192)
Grass and pollen (1)
Guidances (29)
Healthcare (6405)
Huntington's disease (1)
IgA nephropathy (13)
Immunology and inflammation (18)
Indications (20)
Infectious disease (681)
Inflammatory bowel disease (63)
Influenza (12)
Intellectual property (28)
Interviews (72)
IPO (6489)
IRA (4)
Job creations (1115)
Job search strategy (390)
Kidney cancer (8)
Labor market (2)
Layoffs (99)
Leadership (3)
Legal (2292)
Liver cancer (30)
Lung cancer (132)
Lymphoma (41)
Machine learning (1)
Management (20)
Manufacturing (71)
MASH (14)
Medical device (5635)
Medtech (5636)
Mergers & acquisitions (7390)
Metabolic disorders (230)
Multiple sclerosis (20)
NASH (1)
Neurodegenerative disease (14)
Neuropsychiatric disorders (3)
Neuroscience (586)
NextGen: Class of 2025 (1979)
Non-profit (1462)
Northern California (735)
Now hiring (4)
Obesity (110)
Opinion (50)
Ovarian cancer (43)
Pain (20)
Pancreatic cancer (18)
Parkinson's disease (46)
Partnered (2)
Patents (52)
Patient recruitment (35)
Peanut (16)
People (22984)
Pharmaceutical (9)
Phase I (6884)
Phase II (10996)
Phase III (9647)
Pipeline (445)
Podcasts (6)
Policy (11)
Postmarket research (1147)
Preclinical (2813)
Press Release (15)
Prostate cancer (31)
Psychedelics (3)
Radiopharmaceuticals (109)
Rare diseases (91)
Real estate (1787)
Recruiting (20)
Regulatory (8379)
Reports (10)
Research institute (839)
Resumes & cover letters (73)
RSV (15)
Schizophrenia (17)
Series A (32)
Series B (22)
Service/supplier (2)
Sickle cell disease (15)
Southern California (708)
Spinal muscular atrophy (31)
Sponsored (7)
Startups (1087)
Stomach cancer (5)
Supply chain (17)
The Weekly (3)
United States (6753)
Vaccines (162)
Venture capitalists (5)
Webinars (6)
Weight loss (52)
Women's health (12)
Worklife (5)
Date
Today (39)
Last 7 days (175)
Last 30 days (1027)
Last 365 days (11965)
2025 (2600)
2024 (12584)
2023 (14919)
2022 (20712)
2021 (21773)
2020 (20272)
2019 (17327)
2018 (13207)
2017 (13567)
2016 (12348)
2015 (15256)
2014 (10902)
2013 (8488)
2012 (9321)
2011 (9774)
2010 (8719)
Location
Africa (277)
Alabama (8)
Alaska (1)
Arizona (45)
Arkansas (3)
Asia (16767)
Australia (2954)
California (1706)
Canada (596)
China (220)
Colorado (70)
Connecticut (65)
Delaware (61)
Europe (46778)
Florida (259)
Georgia (85)
Idaho (25)
Illinois (154)
India (11)
Indiana (137)
Iowa (2)
Japan (88)
Kansas (27)
Kentucky (6)
Louisiana (4)
Maine (37)
Maryland (244)
Massachusetts (1236)
Michigan (76)
Minnesota (122)
Missouri (33)
Montana (12)
Nebraska (7)
Nevada (22)
New Hampshire (27)
New Jersey (647)
New Mexico (6)
New York (483)
North Carolina (312)
North Dakota (3)
Northern California (735)
Ohio (74)
Oklahoma (4)
Oregon (14)
Pennsylvania (414)
Puerto Rico (5)
Rhode Island (7)
South America (484)
South Carolina (7)
Southern California (708)
Tennessee (20)
Texas (202)
Utah (50)
Virginia (31)
Washington D.C. (11)
Washington State (162)
West Virginia (2)
Wisconsin (16)
251,154 Results for "endo international plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & acquisitions
Troubled Drugmakers Mallinckrodt, Endo Officially Announce $6.7B Merger
Both Mallinckrodt and Endo have previously declared bankruptcy, linked to opioid-related lawsuits.
March 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Endo Announces Divestiture of International Pharmaceuticals Business
March 11, 2025
·
4 min read
Press Releases
Endo Presents Healthcare Provider Survey at Joint Meeting of International Society for the Study of Women’s Sexual Health (ISSWSH) and International Society for Sexual Medicine (ISSM)
February 27, 2025
·
4 min read
Press Releases
Mallinckrodt and Endo to Combine to Create a Global, Scaled, Diversified Pharmaceuticals Leader
March 13, 2025
·
28 min read
Business
Endo Reports Fourth-Quarter 2023 Financial Results
Endo International plc reported financial results for the fourth-quarter ended December 31, 2023.
March 6, 2024
·
34 min read
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo International plc (OTC: ENDPQ) announced today that one of its operating companies, Par Pharmaceutical, Inc., launched ibuprofen-famotidine 800 mg/26.6 mg tablets, a generic version of Amgen’s (formerly Horizon Therapeutics) DUEXIS®.
March 26, 2024
·
13 min read
Endo’s Paladin Labs Announces Launch of XCOPRI® (cenobamate tablets) in Canada
Paladin Labs Inc., a subsidiary of Endo International plc (OTC: ENDPQ), announced today that XCOPRI® (cenobamate tablets) is now available in Canada.
January 22, 2024
·
7 min read
Press Releases
Endo Reschedules Release of Fourth Quarter and Full Year 2024 Earnings Results and Conference Call
March 11, 2025
·
1 min read
Press Releases
Endo Announces Peyronie’s Disease Presentation at the Annual Meeting of the Southeastern Section of the American Urological Association
March 12, 2025
·
9 min read
Pharm Country
Endo Announces Commencement of OTCQX Trading
Endo, Inc. announced that the Company has commenced trading on the OTCQX® Best Market under the ticker symbol NDOI.
June 28, 2024
·
3 min read
1 of 25,116
Next
